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ABSTRACT
The S-adenosylmethionine (AdoMet) analog sine-
fungin is a natural product antibiotic that inhibits
nucleic acid methyltransferases and arrests the
growth of unicellular eukarya and eukaryal viruses.
The basis for the particular sensitivity of fungi and
protozoa to sinefungin is not known. Here we report
the isolation and characterization of spontaneous
sinefungin-resistant mutants of the budding yeast
Saccharomyces cerevisiae. In all cases, sinefungin
resistance was attributable to a loss-of-function
mutation in Sam3, the yeast high-affinity AdoMet
transporter. Overexpression of wild-type Sam3
increased the sensitivity of yeast to growth inhibi-
tion by sinefungin. Thus, Sam3 is a tunable determi-
nant of sinefungin potency. The shared ability of
protozoan parasites to import AdoMet might deter-
mine sinefungin’s anti-infective spectrum. Insights
to the intracellular action of sinefungin stem from
the finding that increased gene dosage of yeast
AdoMet synthase plus cap guanine-N7 methyltrans-
ferase afforded greater resistance to sinefungin
than either enzyme alone. These results are con-
sistent with the proposal that mRNA cap methyla-
tion is a principal target of sinefungin’s bioactivity.
INTRODUCTION
Sinefungin is a natural product analog of S-adenosyl-
methionine (AdoMet) that has antifungal, antiprotozoal
and antiviral activities (1–10). Sinefungin diﬀers from
AdoMet in that the S–CH3 sulfonium moiety is replaced
by a C–NH3 amine. Sinefungin inhibits a wide spectrum of
AdoMet-dependent nucleic acid methyltransferases
in vitro, by competing with AdoMet for occupancy of
the methyl donor site on the enzyme (9,11–14). Several
studies suggest that sinefungin’s antiviral and antifungal
properties derive from selective inhibition of pathogen-
encoded mRNA cap-methylating enzymes, speciﬁcally
RNA (guanine-N7) methyltransferase, which adds a
methyl group from AdoMet to GpppRNA to form the
m
7GpppRNA cap (3,8–10). The cap promotes eukaryal
translation initiation and protects RNAs from degrada-
tion by 50-exoribonucleases.
The budding yeast Saccharomyces cerevisiae cap
methyltransferase Abd1 is exquisitely sensitive to sinefun-
gin in vitro (IC50 of 24nM sinefungin at 25mM AdoMet);
indeed, sinefungin is 900-fold more potent than the
product AdoHcy in inhibiting cap methylation by Abd1
(9). Two recent studies implicated cap methylation as an
antifungal target of sinefungin in vivo. First, isogenic
S. cerevisiae strains containing fungal versus mammalian
mRNA capping systems (15) displayed 5-fold diﬀerences
in sensitivity to growth inhibition by sinefungin that
correlated with the source of the cap (guanine-N7)
methyltransferase component—the strain with the
human cap methyltransferase being more resistant to
sinefungin (8). Second, the susceptibility of budding yeast
to growth inhibition by sinefungin was diminished when
Abd1 was overexpressed by increased gene dosage (9).
To better understand sinefungin’s antifungal mecha-
nism, we attempted to identify missense mutations in the
yeast cap methyltransferase that confer sinefungin resis-
tance in vivo. The approach was to select for outgrowth of
sinefungin-resistant (sfr) cells from a pool of yeasts
containing mutagenized (but functional) ABD1 genes on
a single-copy plasmid. Although forced passage in liquid
culture in the presence of 10mM sinefungin yielded
resistant strains, it quickly became apparent that the
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plasmid. Genetic tests assigned sinefungin-resistance to
SAM3, which encodes the yeast high-aﬃnity AdoMet
transporter (16,17). Spontaneous sfr Sam3 mutations
resulted in loss of function in AdoMet uptake, as
gauged by growth on medium containing exogenous
AdoMet as the sulfur source. We found that over-
expression of wild-type Sam3 increased the sensitivity of
yeast to growth inhibition by sinefungin. Our results
highlight sinefungin uptake by an AdoMet transporter as
a critical determinant of its antifungal activity. The shared
capacity of many unicellular parasites to import AdoMet
(18–20) is likely to underlie sinefungin’s broad anti-
infective spectrum. The ﬁnding that overexpression of
Abd1 plus AdoMet synthase confers sinefungin resistance
in a wild-type SAM3 background provides further
support for the proposal that cap methylation is the
principal intracellular target for sinefungin.
MATERIALS AND METHODS
Yeaststrains and media
All S. cerevisiae strains used in this study are haploid
derivatives of W303 with the following genotype: ura3-1
ade2-1 trp1-1 his3-11,15 leu2-3,112 can1-100. The non-
essential SAM3 gene was replaced with a sam3::kanMX
cassette in which the SAM3 open reading frame was
deleted and substituted by a bacterial gene that confers
resistance to the antibiotic G418. Minimal B medium
lacking exogenous sulfur was prepared as described in
(21). B medium plates contained 1% agarose (from EMD
Chemicals, Inc.) instead of agar. Sinefungin was pur-
chased from Sigma.
Initial selection forsinefungin resistance
We generated a new library of PCR-mutated ABD1 alleles
(ABD1
 )i naCEN TRP1 plasmid under the control of the
ABD1 promoter according to methods described pre-
viously (22), with minor modiﬁcations of the PCR
reaction conditions. The pABD1
  library was transformed
into a S. cerevisiae abd1  pABD1 (CEN URA3 ABD1)
strain and Trp
+ colonies were subjected to two rounds of
replica-plating on medium containing 5-ﬂuoroorotic acid
(FOA) to select for loss of the URA3-marked pABD1
plasmid. Approximately 2500 FOA-resistant abd1D
pABD1
  colonies were harvested directly from agar
plates and then divided into 15 separate pools that were
stored in 17% glycerol at  808C. Aliquots (50ml) from
each pool were inoculated into 1ml of YPD medium
containing 10mM sinefungin. A control aliquot was
inoculated into YPD medium with no drug. The cultures
were incubated for 24h at 308C with constant shaking.
Whereas the control culture became turbid after 24h
(A600>4.0), the sinefungin-containing cultures did not.
Cells were collected by centrifugation from the sinefungin-
containing cultures and resuspended in 1ml of fresh YPD
medium with 10mM sinefungin. Incubation was continued
for another 24h, at which time the cells were again
collected by centrifugation and resuspended in fresh
medium with 10mM sinefungin. After the third 24h
incubation, several of the sinefungin-containing cultures
had become moderately turbid. Aliquots of those cultures
were added to 1ml of fresh medium with 10mM sinefungin
to attain an A600 of 0.1. After incubation for another 24h,
these cultures were fully turbid. Single colonies were
obtained from the cultures by plating on YPD agar.
Sinefungin resistance was conﬁrmed by inoculation of
single colonies into YPD medium with 10mM sinefungin
and assessment of turbidity after overnight growth.
Several of the cultures that had grown out in the presence
of 10mM sinefungin were subjected to dose escalation by
serially inoculating them at 1-day intervals into YPD
containing 20, 40, and 80mM sinefungin. Single colonies
were recovered at each step by plating on YPD agar.
pABD1
  DNA was recovered from individual sfr strains
and ampliﬁed clonally by transformation in Escherichia
coli.p ABD1
  DNAs isolated from bacteria were trans-
formed into S. cerevisiae abd1  pABD1 (CEN URA3
ABD1) and exchanged for the wild-type pABD1 plasmid
by selection on medium containing FOA. In no instance
was the resulting pABD1
  yeast strain capable of growing
during a 24h incubation in YPD medium with 10mM
sinefungin. Thus, the sinefungin-resistant phenotype was
apparently not linked to the ABD1
  plasmid. This
conclusion was veriﬁed by transforming several of the
sfr strains with wild-type pABD1 and then screening for
spontaneous loss of the pABD1
  (TRP1) plasmid by
tryptophan auxotrophy. The reintroduction of wild-type
ABD1 did not ameliorate the sinefungin-resistance,
implying that the putative resistance-conferring muta-
tion(s) reside in one or more yeast chromosomal genes.
The sfr abd1  pABD1 strains were backcrossed to a
sinefungin-sensitive ABD1 strain and the diploids were
subjected to sporulation and tetrad dissection. The
haploid progeny of four-spore tetrads were screened for
sensitivity to sinefungin by spotting aliquots of the drug
on a freshly plated lawn of cells and assessing the size of
any resulting zone of growth inhibition (9). Sensitivity and
resistance segregated in a 2:2 pattern (Figure 1), suggest-
ing that resistance was conferred by mutation of a single
genetic locus. Haploid sfr Mata progeny that contained a
wild-type chromosomal ABD1 locus were selected for
further study. These sfr strains were provisionally
designated sfr-1, sfr-2, sfr-3, etc.
RESULTS
Sinefungin-resistant yeast mutants
We isolated sfr strains by forced passage in liquid cultures
of YPD medium containing 10mM sinefungin. Although
our selection strategy was designed to identify sfr versions
of the yeast cap methyltransferase Abd1, initial genetic
linkage tests showed that none of the yeast strains that
grew in the presence of sinefungin did so because of
resistance-conferring changes in the plasmid-borne ABD1
gene. By backcrossing the sfr strains to a sinefungin-
sensitive yeast strain, and then subjecting the diploids to
sporulation and tetrad analysis, we obtained evidence that
drug-resistance was caused by a mutation that segregated
2:2 with drug sensitivity. Figure 1 illustrates the use of a
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of the four haploid progeny of one such backcross.
Aliquots (2ml) of an aqueous solution of sinefungin (either
0.25, 0.5, 1.0, or 2.0mM) were spotted on a freshly plated
lawn of yeast cells on YPD agar medium. In the case of
two of the haploid progeny (Figure 1A and D), diﬀusion
of the drug from the site of application resulted in a
circular zone of growth inhibition with a sharp demarca-
tion at the circumference. The diameter of the zone of
inhibition increased with the increasing sinefungin con-
centration, as expected. The two other haploid progeny
(Figure 1B and C) showed hardly any zone of growth
inhibition at even the highest sinefungin dose. Three other
tetrads from the same diploid also yielded two sinefungin-
sensitive and two sfr haploid progeny (data not shown).
This pattern of meiotic segregation is consistent with
sinefungin resistance being caused by a single-gene
mutation.
Sinefungin-resistant mutants aredefective in utilization
of exogenous AdoMet
sfr haploids that contained a wild-type chromosomal
ABD1 locus after backcrossing were selected for further
study. These sfr strains were provisionally designated
sfr-1, sfr-2, sfr-3, sfr-4, etc. We considered several possible
mechanisms for drug resistance including: (i) defective
uptake of sinefungin from the medium; (ii) enhanced
export of sinefungin out of the cell; (iii) accelerated
metabolism of sinefungin to an inactive derivative;
and (iv) resistance-conferring changes in an AdoMet-
dependent methyltransferase other than Abd1. Our ﬁrst
suspicions focused on drug export in light of the well-
studied phenomenon of yeast pleiotrophic drug resistance
(PDR), which is caused by gain-of-function mutations in
transcription factors that increase the level of expression
of the ATP-dependent plasma membrane pumps that
expel various xenobiotics from the cell (23). However, two
preliminary results obtained by spot-testing for drug
inhibition hinted that sinefungin resistance might not be
mediated via PDR. First, the yeast sfr strains were no less
sensitive than the parental wild-type to cycloheximide, a
substrate for export by the PDR system. Second, a yeast
pdr1  strain, which lacks a master transcriptional
regulator of expression of the export pumps, was not
more sensitive than a PDR1 strain to sinefungin.
The prospect that sinefungin-sensitivity might rely on
the same pathway used to assimilate exogenous AdoMet
was suggested by an initial ﬁnding that the zone of
inhibition of the wild-type yeast strain in the sinefungin
spot test was diminished progressively by including
increasing concentrations of AdoMet in the spotted
solution along with a ﬁxed concentration of sinefungin
(data not shown). One explanation for this eﬀect
(though by no means the only one) is that sinefungin
and AdoMet compete for a common yeast transport
system. Saccharomyces cerevisiae can take up AdoMet
from the medium; this capacity is not essential for growth
under normal conditions, but becomes critical when the
paralogous yeast SAM1 and SAM2 genes encoding
AdoMet synthase are inactivated simultaneously, result-
ing in AdoMet auxotrophy (24). The uptake of AdoMet
by S. cerevisiae requires Sam3, a 587-aa integral membrane
protein that belongs to the amino acid permease super-
family (16). Although a yeast sam3  mutant is viable, the
strain is defective for growth on B medium (a minimal
medium lacking sulfur) when exogenous AdoMet is
included as the lone sulfur source (16).
To test whether the four sfr strains were defective in
utilizing exogenous AdoMet, we spotted serial dilutions of
wild-type, sfr, and sam3  cells on unsupplemented
B medium and on B medium containing either AdoMet
or methionine as the sulfur source (Figure 2). All of
the strains were impaired for growth on B medium. The
sam3  mutant was unable to grow using AdoMet as the
sulfur source, yet it was able to grow in the presence of
methionine, as reported previously (16). The wild-type
strain was the only one for which growth was restored by
AdoMet. Each of the sfr strains phenocopied sam3  with
respect to their ability to utilize methionine but not
AdoMet (Figure 2). These results underscore a correlation
between impaired AdoMet uptake and sinefungin-
resistance in yeast. Yet, they do not reveal whether the
sfr mutations elicit a sam3-like phenotype directly, via
mutations in Sam3, or indirectly, through mutations in
genes that regulate Sam3 expression or function.
Figure 1. Meiotic segregation of sinefungin resistance. The four haploid
progeny (A, B, C and D) were grown in YPD medium to mid-log phase
and aliquots (10
6 cells) were spread on YPD agar plates (15-cm
diameter). After incubation of the plates for 1h at 308C to allow the
cell suspension to dry, 2ml aliquots of aqueous solutions of sinefungin
(0.25, 0.5, 1.0 or 2.0mM as diagrammed at the bottom) were spotted
on the agar plates. The plates were incubated for 2 days at 308C and
then photographed.
Nucleic Acids Research, 2007, Vol. 35, No. 20 6897sfr mutants areallelic toSAM3
To better quantify sinefungin resistance and simulta-
neously compare the sensitivities of various mutants
strains, we applied 150ml aliquots of 0.5, 1, 2 and 20mM
sinefungin stock solutions to the surfaces of YPD agar
plates (containing 25ml of medium) and allowed the
drug to adsorb into the agar before spotting serial
dilutions of wild-type, sfr, and sam3  cells. (If one
assumes that the applied drug is evenly distributed
through the z-plane of the agar plate, then these doses
correspond to net sinefungin concentrations of 3, 6, 12
and 120mM, respectively.) Wild-type yeast cells failed to
grow on plates that had received  0.5mM sinefungin
(Figure 3). Back titration of the applied dose revealed
that 150ml of a 0.2mM sinefungin solution suﬃced to
prevent growth of the wild-type yeast strain on a YPD
agar plate (data not shown). The sam3  strain was
impervious to the 20mM dose of sinefungin, which
translates into at least 100-fold resistance compared to
the wild-type strain (Figure 3). This result signiﬁes that
sinefungin is transported into yeast cells by the same
permease that transports AdoMet. The sfr-1 and sfr-3
strains phenocopied sam3  with respect to resistance to
the highest level of sinefungin (Figure 3). However,
growth of the sfr-2 and sfr-4 strains, though resistant to
the 0.5mM sinefungin dose, was slowed at the 2mM
dose and inhibited fully by the 20mM dose (Figure 3).
These results highlight heterogeneity of the resistance
phenotypes of diﬀerent sfr strains.
To test whether the sfr mutations were allelic to SAM3,
the sfr and sam3  strains were transformed with a CEN
TRP1 plasmid bearing the wild-type SAM3 gene under
the control of its native promoter. The strains were
transformed in parallel with the empty CEN TRP1
plasmid vector. The SAM3 plasmid restored sinefungin
sensitivity to the sam3  strain (Figure 4). The sfr-1, sfr-2,
sfr-3, and sfr-4 strains were also rendered sinefungin-
sensitive by the plasmid-borne SAM3 gene (Figure 4),
implying that the sfr mutations are recessive and allelic to
SAM3. The results are not consistent with the sfr
mutations aﬀecting a regulator of SAM3 expression or
function, insofar as a single copy of the SAM3 gene on a
plasmid would not be expected to restore Sam3 activity in
such a scenario.
Sinefungin resistance is caused by avarietyof mutations
in theSAM3 gene
Convincing evidence that mutations in the SAM3 gene
were the cause of spontaneous sinefungin-resistance was
obtained by PCR-amplifying, cloning, and sequencing the
SAM3 locus from the wild-type, sfr-1, sfr-2, sfr-3, and
sfr-4 strains. Four plasmid clones were sequenced from
each strain to avoid specious attribution of phenotypes to
PCR-generated changes. The sequence of the wild-type
SAM3 open reading frame encoded a 587-aa polypeptide
identical to the wild-type Sam3 reported previously (16).
The sfr-1 strain had a single nucleotide coding change in
the SAM3 gene that resulted in a stop codon in lieu of the
codon for Ser444 (Table 1). The sfr-3 strain had a
2-nucleotide deletion in the codons for Val371 and
Ser372; the  2 frameshift created a mutant peptide
sequence from Leu373 to the truncated C-terminus at
Gly404 (Table 1). Note that the protein truncations
caused by sfr-1 and sfr-3 mutations mimicked the null
phenotype of the sam3  deletion with respect to extreme
sinefungin-resistance (Figure 3). By contrast, the sfr-2 and
sfr-4 strains, which were less resistant to sinefungin than
Figure 3. Sinefungin resistance of sfr and sam3  strains. The indicated yeast strains were grown in YPD medium at 308C until A600 reached  0.7.
The cells were harvested by centrifugation and suspended in water. Serial 10-fold dilutions were prepared and aliquots (2ml) were spotted on an
unsupplemented agar plate (‘none’) and on YPD agar plates onto which 150ml aliquots of a sinefungin solution (0.5, 1, 2 or 20mM) had been
applied and spread. If one assumes that the applied drug is evenly distributed through the depth of the agar plate, then these doses correspond to net
sinefungin concentrations of 3, 6, 12 and 120mM, respectively. The plates were photographed after incubation for 2 days at 308C.
Figure 2. The sfr strains are defective in utilization of exogenous
AdoMet. The indicated yeast strains were grown in YPD medium at
308C until A600 reached  0.7. The cells were harvested by centrifuga-
tion, suspended in water, recentrifuged and resuspended in water. Serial
10-fold dilutions (in water) of the washed cells were prepared and
aliquots (2ml) were spotted on B medium agarose plates or B medium
supplemented with 0.5mM AdoMet or 0.1mM methionine. The plates
were photographed after incubation for 2 days at 308C.
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tions in the SAM3 gene that resulted in E213K and S476F
changes in the Sam3 protein, respectively. We surmise that
the defective Sam3 E213K and S476F proteins retained
some low level of transport function in vivo that allowed
uptake of sinefungin when the drug was present at very
high concentration in the medium.
To check that the SAM3 alleles obtained from these
four sfr strains were indeed functionally compromised, we
cloned them into CEN TRP1 plasmids and then used these
vectors, and a wild-type SAM3 control, to transform the
sam3  strain. The transformants were tested for growth
on Trp
  plates that had been overlaid with 0.5 or 2mM
sinefungin. The wild-type SAM3 gene restored sinefungin-
sensitivity, but the empty vector control did not, nor did
any of the four mutated sam3 genes from the sfr strains
(Figure 5).
To better survey the spectrum of spontaneous Sam3
lesions that cause sinefungin-resistance, we sequenced the
SAM3 locus from eight additional sfr strains isolated in
the screen. The sfr-5, sfr-10 and sfr-11 strains had single
nucleotide changes that resulted in translation stops at the
codons for amino acids 180, 400 and 60, respectively
(Table 1). The sfr-6, sfr-7 and sfr-9 strains had single
nucleotide mutations that resulted in Q126P, S171R and
S171R missense changes in Sam3, respectively. Note that
the identical S171R protein mutations in the sfr-7 and
sfr-9 strains were the result of independent spontaneous
mutations of the Ser171 AGC codon to AGA and AGG
arginine codons, respectively (Table 1). The sfr-8 and
sfr-12 strains had single nucleotide deletions in the codons
for Pro262 and Thr90, respectively; the  1 frameshifts
created mutant C-terminal Sam3 peptides that stopped
after Ser282 and Val98, respectively (Table 1). These
results underscore that complete inactivation of Sam3 by a
protein-truncating stop codon is the predominant route to
sinefungin resistance.
Overexpression of Sam3sensitizes yeast tosinefungin
We reasoned that if loss of Sam3 transporter function
results in sinefungin resistance, then overexpression of
Sam3 might enhance the sinefungin sensitivity of
S. cerevisiae. Previous studies had established that
introducing SAM3 on a high copy plasmid into a wild-
type SAM3 strain elicited a 3.5-fold increase in AdoMet
uptake (16). We expected that SAM3 overexpression
would also increase sinefungin bioavailability. Thus, we
cloned the wild-type SAM3 gene into a high-copy 2m
HIS3 plasmid and then introduced the 2m SAM3 plasmid
into wild-type yeast, in parallel with the empty 2m vector.
The transformants were tested for growth on His
  plates
with no added drug and His
  plates that had been
overlaid with sinefungin. Preliminary experiments estab-
lished that growth of wild-type yeast cells was suppressed
by applying 150ml of a 25–50mM solution of sinefungin to
the minimal agar medium. Thus, we tested for the eﬀects
of Sam3 overexpression at lower doses of sinefungin
(150ml of a 1.6mM or 3.1mM sinefungin solution) and
observed that increasing the copy number of the SAM3
gene sensitized the cells to inhibition of growth by a
sinefungin dose that had little impact on cells that had
only a single copy of SAM3 (Figure 6). Thus, Sam3 is a
tunable determinant of sinefungin sensitivity and
resistance.
Overexpression of AdoMetsynthase plus cap
methyltransferase confers sinefungin resistance
The genetic studies presented above highlight Sam3 as the
major determinant of sinefungin susceptibility of budding
Figure 4. SAM3 restores sinefungin sensitivity to yeast sfr strains. The
indicated yeast strains were transformed with either the control CEN
TRP1 plasmid or a derivative bearing wild-type SAM3. Cells were
grown in Trp
  medium at 308C until A600 reached  0.7, then harvested
by centrifugation and suspended in water. Serial 10-fold dilutions were
prepared and aliquots (2ml) were spotted on an unsupplemented Trp
 
agar plate (‘no drug’) and on a Trp
  plate onto which 150mlo fa
0.5mM sinefungin solution had been applied and spread. The plates
were photographed after incubation for 3 days at 308C.
Figure 5. Sinefungin phenotype of sfr sam3  strains. sam3  cells
transformed with a CEN TRP1 vector containing the genes speciﬁed at
left were grown in Trp
  medium at 308C until A600 reached  0.7. The
cells were harvested by centrifugation and suspended in water. Serial
10-fold dilutions were prepared and aliquots (2ml) were spotted on an
unsupplemented Trp
  agar plate (‘no drug’) and on Trp
  plates onto
which 150ml of a 0.5mM or 2mM sinefungin solution had been applied
and spread. The plates were photographed after incubation for 3 days
at 308C.
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of the drug once it is taken up from the medium. If
sinefungin is blocking growth by acting as a competitive
inhibitor of AdoMet binding to an essential yeast
methyltransferase, then we reasoned that increasing the
intracellular level of AdoMet might ameliorate the eﬀects
of sinefungin on its methyltransferase target. S. cerevisiae
encodes two AdoMet synthases: Sam1 and Sam2 (24).
Previous ﬁndings that increased SAM1 or SAM2 gene
dosage can suppress temperature-sensitive abd1 mutations
(22) implied that Abd1 function is responsive to intracel-
lular AdoMet levels. Here we introduced into yeast a
multicopy 2m URA3 plasmid containing SAM1 or SAM2
under the control of the constitutive yeast TPI1 promoter
(22). Compared to an empty 2m URA3 vector control,
overexpression of either isozyme of AdoMet synthase
enhanced cell growth on minimal medium overlaid with
150mlo f2 5mMo r5 0mM sinefungin, but did not allow for
growth at a higher drug dosage (Figure 7A). Transforma-
tion of yeast with a 2m TRP1 plasmid containing wild-
type ABD1 driven by the TPI1 promoter also enabled
growth on minimal medium dosed with 150mlo f2 5 mM
sinefungin (Figure 7B), but not with  50mM sinefungin
(not shown). Cotransformation with 2m ABD1 plus either
2m SAM1 or 2m SAM2 plasmids had an additive eﬀect on
sinefungin-resistance, whereby the strains overexpressing
AdoMet synthase and cap methyltransferase grew on
minimal medium overlaid with 150ml of 100mM sinefun-
gin, a condition in which neither wild-type yeast nor yeast
overexpressing Sam1 or Sam2 alone were able to form
colonies (Figure 7A).
DISCUSSION
A classical genetic approach to identifying the target of a
drug is to screen for a drug-resistant mutant and then
identify the gene responsible for the resistance phenotype.
There have been several earlier reports of the isolation of
sfr mutants or resistant strain variants of protozoan
organisms that are normally sensitive to the drug (25–30).
An sfr isolate of Leishmania displayed impaired uptake of
sinefungin compared with the wild-type strain (30). The
present study shows that impaired sinefungin uptake
is the predominant route to spontaneous sinefungin-
resistance of S. cerevisiae, which is caused by a variety of
loss-of-function mutations in the yeast high-aﬃnity
AdoMet transporter Sam3. To our knowledge, sinefungin
resistance-conferring genetic changes in a free-living org-
anism had not been assigned previously to speciﬁc genes.
SAM3 was identiﬁed initially by Rouillon et al. (16) as a
gene required for growth of budding yeast on sulfur-free
medium containing AdoMet as the sole sulfur source. The
Sam3 protein consists of 12 putative membrane-spanning
segments and is classiﬁed as a member of the amino acid
permease superfamily. Sam3 is capable of discriminating
structurally related sulfonium derivatives of methionine,
insofar as Sam3 suﬃces to transport AdoMet, but not
S-methylmethionine (16). The genetic evidence presented
here indicates that Sam3 is the principle (if not the only)
yeast transporter of sinefungin. Although sinefungin has a
Table 1. Spontaneous SAM3 mutations that confer sinefungin resistance
sfr allele Sam3 protein mutations SAM3 DNA mutations
sfr-1 Ser444!ter TCA!TAA
sfr-2 Glu213!Lys GAG!AAG
sfr-3
371VSVCNSCVYASSRLIQALGASGQLPSVCSYMDRK...!
371VSLQFLRLCFFKTNSSFRCIWPTSFGMFLHGQKG
404(ter)
 2 frameshift
GTGTCAGTT!GTCAGTTTG
sfr-4 Ser476!Phe TCC!TTC
sfr-5 Ser180!ter TCA!TAA
sfr-6 Gln126!Pro CAG!CCG
sfr-7 Ser171!Arg AGC!AGA
sfr-8
262PVFKNLCNTFVSAAFSFGGSEL...!
262LSSRICVTHSFLLFPLVVS
282(ter)
 1 frameshift
CCTGTC!CTGTCT
sfr-9 Ser171!Arg AGC!AGG
sfr-10 Tyr400!ter TAC!TAA
sfr-11 Glu60!ter GAG!TAG
sfr-12
90TLGTGLFIGL...!
90PWGRDCSLV
98(ter)
 1 frameshift and T!C
ACTTTG!CCTTGG
The sfr strains were selected for growth by passage in YPD medium with 10mM sinefungin, except for sfr-1 and sfr-5, which were subjected to dose
escalation and selection for growth in 80mM sinefungin. The nucleotide changes in the SAM3 genes of each strain are shown in the right column.
Single missense or nonsense nucleotide changes in the sfr strains are underlined. The nucleotides of the wild-type SAM3 gene that were deleted in the
sfr-3, sfr-8, and sfr-12 strains are shown in italics. The resulting mutations in the Sam3 protein are indicated in the middle column.
Figure 6. Sam3 overexpression sensitizes yeast to sinefungin inhibition.
Wild-type SAM3 cells were transformed with 2m SAM3 or 2m plasmids
and grown in His
  medium at 308C until A600 reached  0.7. The cells
were harvested by centrifugation and suspended in water. Serial 10-fold
dilutions were prepared and aliquots (2ml) were spotted on an
unsupplemented His
  agar plate (‘no drug’) and on His
  plates onto
which 150ml of a 1.6mM or 3.1mM sinefungin solution had been
applied and spread. If the applied drug is evenly distributed through
the depth of the agar plate, these doses correspond to net sinefungin
concentrations of about 10 and 19 nM, respectively. The plates were
photographed after incubation for 3 days at 308C.
6900 Nucleic Acids Research, 2007, Vol. 35, No. 20primary amine instead of the sulfonium center found in
AdoMet, the two compounds are virtually isosteric and
both have a positive charge on the amine/sulfonium
groups. Thus, it is sensible that Sam3 would be able to
transport sinefungin. A recent study suggests that Sam3 is
also able to transport other positively charged compounds
such as putrescine and spermidine (17).
The Sam3 mutations that confer sinefungin-resistance
also result in loss-of-function in AdoMet uptake, as
gauged by impaired growth on AdoMet-containing B
medium. Most of the sfr mutants isolated in the screen
are functionally null for Sam3 because of premature
translation stops that remove three or more of the 12
predicted membrane-spanning segments. The Sam3 mis-
sense mutations that confer sinefungin-resistance are
Q126P, S171R, E213K, and S476F. Gln126, Ser171 and
Ser476 are located in predicted membrane spanning
segments 2, 3 and 11, respectively. Glu213 is situated
between the third and fourth membrane-spanning
segments. All four of these Sam3 side chains are
conserved in the yeast Mmp1 permease that transports
S-methylmethionine (16).
Our ﬁndings that sinefungin’s antifungal activity is
contingent on its import by the yeast AdoMet permease
resonate strongly with previous studies of AdoMet and
sinefungin in protozoan parasites. Sinefungin-sensitive
kinetoplastid parasites such as Leishmania and
Trypanosoma can import exogenous AdoMet. Inhibition
of AdoMet uptake by sinefungin and direct assays of
intracellular sinefungin accumulation suggest that kineto-
plastids import sinefungin via the AdoMet uptake path-
way (19,20,30,31). Resistance of Leishmania to sinefungin
is correlated with decreased uptake of both sinefungin and
AdoMet (30,31). To our knowledge, there has been no
published report of the identiﬁcation of the gene encoding
the putative kinetoplastid AdoMet/sinefungin transporter.
To a ﬁrst approximation, it appears that the anti-
infective spectrum of sinefungin correlates with the
presence in the susceptible organisms of an AdoMet
transport system that accepts sinefungin as cargo. The
acquisition of spontaneous sinefungin-resistance by inac-
tivating mutations of the fungal AdoMet permease is a
potential obstacle to sustained clinical eﬃcacy of a
sinefungin-based drug. However, this problem is less
daunting if the parasite relies on AdoMet uptake for
growth or persistence in the animal host, in which case
mutations in the AdoMet transporter that aﬀect sinefun-
gin susceptibility would simultaneously diminish the
virulence of the parasite. This is a plausible scenario for
the fungal pathogen Pneumocystis carinii, which has no
detectable AdoMet synthase activity and is naturally
auxotrophic for exogenous AdoMet taken up by a high-
aﬃnity transporter (18). Sinefungin inhibits Pneumocystis
growth in culture (32).
The fact that the sfr phenotype in yeast is dominated by
sam3 mutations confounded our initial eﬀorts to identify
an intracellular methyltransferase target of sinefungin
by screening haploid strains for drug-resistance. Because
the sinefungin-sensitive trait of wild-type SAM3 is
dominant in the presence of a sfr sam3 allele, it might be
feasible to screen in diploid strains for non-Sam3
resistance-conferring changes. However, we observed the
rapid emergence of sfr colonies in the middle of the zone
of inhibition when drug was spotted on a lawn of the
SAM3 sam3(sfr-1) diploid strain (data not shown). We
surmise that gene conversion between homologous chro-
mosomes resulted in transfer of the resistance mutation to
the previously wild-type SAM3 locus. A potentially better
Figure 7. Increased gene dosage of SAM1 or SAM2 plus ABD1 confers sinefungin-resistance. (A) Yeast abd1  cells containing either a CEN TRP1
ABD1 plasmid (with ABD1 expression controlled by its native promoter) or a 2m TRP1 ABD1 plasmid (with ABD1 driven by the strong TPI1
promoter) were transformed with a 2m URA3 plasmid bearing either SAM1 or SAM2 or no insert. Transformants were grown in Ura
  medium at
308C until A600 reached  0.7. The cells were harvested by centrifugation and suspended in water. Serial 10-fold dilutions were prepared and aliquots
(2ml) were spotted on an unsupplemented Ura
  agar plate (‘no drug’) and on Ura
  plates onto which 150ml of a 25, 50 or 100mM sinefungin
solution had been applied. If the applied drug is evenly distributed through the depth of the agar plate, these doses correspond to net sinefungin
concentrations of 0.15, 0.3 and 0.6mM, respectively. The plates were photographed after incubation for 3 days at 308C. (B) Aliquots (2ml) of serial
10-fold dilutions of wild-type yeast cells carrying either an empty CEN TRP1 vector or a 2m TRP1 ABD1 plasmid were spotted on an
unsupplemented Trp
  agar plate (‘no drug’) and on Trp
  plates onto which 150mlo fa2 5mM sinefungin solution had been applied. The no drug and
25mM sinefungin plates were photographed after incubation at 308C for 3 days and 5 days, respectively.
Nucleic Acids Research, 2007, Vol. 35, No. 20 6901way to seek resistance mutations in intracellular targets is
to exploit the observation that a 2m SAM3 plasmid
sensitizes yeast to AdoMet. The high copy number of the
2m plasmid makes it unlikely that an inactivating
mutation in the chromosomal SAM3 gene, or any one
of the plasmid-borne genes, will result in resistance in the
presence of an excess of wild-type SAM3 alleles. In this
background, non-Sam3 resistance-conferring mutations
might be identiﬁed.
The observation that wild-type SAM3 cells become sfr
upon overexpression of AdoMet synthase plus Abd1
reinforces the earlier suggestion that RNA cap methyla-
tion is a principal intracellular event targeted by the drug
(8,9). It is sensible that simultaneously increasing the
concentration of the enzyme responsible for AdoMet
production and the level of the relevant methyltransferase
enzyme target should generate greater resistance than
either maneuver alone.
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